Patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) have
a two-to threefold greater risk of developing venous as well as arterial thrombotic events …

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) affects systemic
small vessels and is accompanied by the presence of ANCAs in the serum. This disease …

Antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis is dominated by
inflammatory occlusion of small vessels causing tissue ischemia in a variety of organs. The …

Vascular injury in vasculitis may be due to activation of circulating neutrophils resulting in
their increased adhesiveness to locally activated endothelium (Shwartzman phenomenon) …

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) constitutes a group
of rare diseases characterized by necrotizing inflammation of small blood vessels and the …

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) encompasses a
group of potentially life-threatening disorders characterized by necrotizing small vessel …

Antineutrophil cytoplasmic autoantibodies (ANCA) associated vasculitis (AAV) are a group
of systemic vasculitis characterized by inflammation and necrosis of blood vessel walls …

Antineutrophil cytoplasmic autoantibodies (ANCA)-associated vasculitides (AAV) are a
group of systemic vasculitis syndromes characterized by inflammation and necrosis of blood …

The interplay between neutrophils and endothelial cells allows ANCA to become pathogenic
and results in uncontrolled inflammation in the vessel wall. This review presents an overall …

Objectives Antineutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) is
characterised by neutrophil activation. An elevated prevalence of venous thromboembolic …